GET A GRIP ON:@0.058908:0.816945:0.323595:0.816945:0.323595:0.778949:0.058908:0.778949:0.025457:0.022359:0.021762:0.010041:0.024449:0.010041:0.025457:0.025383:0.011870:0.025233:0.010041:0.026278:0.026316
 :@0.323595:0.816945:0.332890:0.816945:0.332890:0.778949:0.323595:0.778949:0.009295
RHEUMATOID ARTHRITIS:@0.058908:0.845449:0.502505:0.845449:0.502505:0.807453:0.058908:0.807453:0.025383:0.027062:0.021986:0.026577:0.033520:0.022807:0.021239:0.026278:0.011870:0.024375:0.010825:0.024449:0.024487:0.021762:0.027062:0.025383:0.011348:0.021762:0.011870:0.023553
 :@0.300751:0.845449:0.310046:0.845449:0.310046:0.807453:0.300751:0.807453:0.009295
S4  Rheumalef 10 Tablets. Each film-coated tablet contains leflunomide 10 mg. Reg. No. 45/3.1/0404. :@0.059700:0.947832:0.414636:0.947832:0.414636:0.937003:0.059700:0.937003:0.005234:0.004364:0.002182:0.002182:0.005665:0.004364:0.004364:0.004364:0.006536:0.004364:0.001742:0.004364:0.002182:0.002182:0.004364:0.004364:0.002048:0.003923:0.004364:0.004364:0.001742:0.004364:0.002182:0.003923:0.002182:0.002182:0.005234:0.004364:0.003923:0.004364:0.002182:0.001962:0.001962:0.001742:0.006536:0.002612:0.003923:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.002182:0.004364:0.004364:0.001742:0.004364:0.002182:0.002182:0.003923:0.004364:0.004364:0.002182:0.004364:0.001742:0.004364:0.003923:0.002182:0.001742:0.004364:0.001962:0.001962:0.004364:0.004364:0.004364:0.006536:0.001742:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.006536:0.004364:0.002182:0.002182:0.005665:0.004364:0.004364:0.002182:0.002182:0.005665:0.004364:0.002182:0.002182:0.004364:0.004364:0.002182:0.004364:0.002182:0.004364:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.002182
S4  Rheumalef 20 Tablets. Each film-coated tablet contains leflunomide 20 mg. Reg. No. 45/3.1/0405. :@0.059700:0.956904:0.414636:0.956904:0.414636:0.946075:0.059700:0.946075:0.005234:0.004364:0.002182:0.002182:0.005665:0.004364:0.004364:0.004364:0.006536:0.004364:0.001742:0.004364:0.002182:0.002182:0.004364:0.004364:0.002048:0.003923:0.004364:0.004364:0.001742:0.004364:0.002182:0.003923:0.002182:0.002182:0.005234:0.004364:0.003923:0.004364:0.002182:0.001962:0.001962:0.001742:0.006536:0.002612:0.003923:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.002182:0.004364:0.004364:0.001742:0.004364:0.002182:0.002182:0.003923:0.004364:0.004364:0.002182:0.004364:0.001742:0.004364:0.003923:0.002182:0.001742:0.004364:0.001962:0.001962:0.004364:0.004364:0.004364:0.006536:0.001742:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.006536:0.004364:0.002182:0.002182:0.005665:0.004364:0.004364:0.002182:0.002182:0.005665:0.004364:0.002182:0.002182:0.004364:0.004364:0.002182:0.004364:0.002182:0.004364:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.002182
For full prescribing information refer to the package insert approved by the medicines regulatory authority. 201807021087077. :@0.059834:0.965976:0.497631:0.965976:0.497631:0.955147:0.059834:0.955147:0.004794:0.004364:0.002612:0.002182:0.002182:0.004364:0.001742:0.001742:0.002182:0.004364:0.002612:0.004364:0.003923:0.003923:0.002612:0.001742:0.004364:0.001742:0.004364:0.004364:0.002182:0.001742:0.004364:0.002182:0.004364:0.002612:0.006536:0.004364:0.002182:0.001742:0.004364:0.004364:0.002182:0.002612:0.004364:0.002182:0.004364:0.002612:0.002182:0.002182:0.004364:0.002182:0.002182:0.004364:0.004364:0.002182:0.004364:0.004364:0.003923:0.003923:0.004364:0.004364:0.004364:0.002182:0.001742:0.004364:0.003923:0.004364:0.002612:0.002182:0.002182:0.004364:0.004364:0.004364:0.002612:0.004364:0.003923:0.004364:0.004364:0.002182:0.004364:0.003923:0.002182:0.002182:0.004364:0.004364:0.002182:0.006536:0.004364:0.004364:0.001742:0.003923:0.001742:0.004364:0.004364:0.003923:0.002182:0.002612:0.004364:0.004364:0.004364:0.001742:0.004364:0.002182:0.004364:0.002612:0.003923:0.002182:0.004364:0.004364:0.002182:0.004364:0.004364:0.002612:0.001742:0.002182:0.003349:0.002182:0.002182:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.002182:0.002182
Adcock Ingram Limited. Reg. No. 1949/034385/06. Private Bag X69, Bryanston, 2021, South Africa. Tel. +27 11 635 0000. www.adcock.com.:@0.059394:0.975048:0.547038:0.975048:0.547038:0.964219:0.059394:0.964219:0.005234:0.004364:0.003923:0.004364:0.003923:0.003923:0.002182:0.002182:0.004364:0.004364:0.002612:0.004364:0.006536:0.002182:0.004364:0.001742:0.006536:0.001742:0.002182:0.004364:0.004364:0.002182:0.002182:0.005665:0.004364:0.004364:0.002182:0.002182:0.005665:0.004364:0.002182:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.002182:0.005234:0.002612:0.001742:0.003923:0.004364:0.002182:0.004364:0.002182:0.005234:0.004364:0.004364:0.002182:0.005234:0.004364:0.004364:0.002182:0.002182:0.005234:0.002612:0.003923:0.004364:0.004364:0.003923:0.002182:0.004364:0.004364:0.002182:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.002182:0.005234:0.004364:0.004364:0.002182:0.004364:0.001751:0.005234:0.002182:0.002612:0.001742:0.003923:0.004364:0.002182:0.002048:0.003923:0.004364:0.001742:0.002182:0.002182:0.004584:0.004364:0.004364:0.002182:0.003790:0.004364:0.002182:0.004364:0.004364:0.004364:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.002182:0.005665:0.005665:0.005234:0.002182:0.004364:0.004364:0.003923:0.004364:0.003923:0.003923:0.002182:0.003923:0.004364:0.006536:0.002182
References::@0.058296:0.880929:0.100602:0.880929:0.100602:0.870099:0.058296:0.870099:0.005665:0.004364:0.002182:0.004364:0.002612:0.004364:0.004364:0.003923:0.004364:0.003923:0.002182
1. Osiri M, Shea B, Welch V, :@0.058296:0.888703:0.159061:0.888703:0.159061:0.877873:0.058296:0.877873:0.004364:0.002182:0.002182:0.006105:0.003923:0.001742:0.002612:0.001742:0.002182:0.006536:0.002182:0.002182:0.005234:0.004364:0.004364:0.004364:0.002182:0.005234:0.002182:0.002182:0.007273:0.004364:0.001742:0.003923:0.004364:0.002182:0.004517:0.002182:0.002182
et al:@0.159061:0.888703:0.173894:0.888703:0.173894:0.878169:0.159061:0.878169:0.004364:0.002182:0.002182:0.004364:0.001742
. Leflunomide for the treatment of rheumatoid arthritis (Review). :@0.173894:0.888703:0.396323:0.888703:0.396323:0.877873:0.173894:0.877873:0.002182:0.002182:0.004364:0.004364:0.001962:0.001962:0.004364:0.004364:0.004364:0.006536:0.001742:0.004364:0.004364:0.002182:0.002182:0.004364:0.002612:0.002182:0.002182:0.004364:0.004364:0.002182:0.002182:0.002612:0.004364:0.004364:0.002182:0.006536:0.004364:0.004364:0.002182:0.002182:0.004364:0.002182:0.002182:0.002612:0.004364:0.004364:0.004364:0.006536:0.004364:0.002182:0.004364:0.001742:0.004364:0.002182:0.004364:0.002612:0.002182:0.004364:0.002612:0.001742:0.002182:0.001742:0.003923:0.002182:0.002612:0.005665:0.004364:0.003923:0.001742:0.004364:0.005665:0.002612:0.002182:0.002182
Cochrane Database of Systematic Reviews:@0.396323:0.888703:0.547222:0.888703:0.547222:0.878169:0.396323:0.878169:0.005665:0.004364:0.003923:0.004364:0.002612:0.004364:0.004364:0.004364:0.002182:0.005665:0.004364:0.002182:0.004364:0.004364:0.004364:0.003923:0.004364:0.002182:0.004364:0.002182:0.002182:0.005234:0.003923:0.003923:0.002182:0.004364:0.006536:0.004364:0.002182:0.001742:0.003923:0.002182:0.005665:0.004364:0.003923:0.001742:0.004364:0.005665:0.003923
 2002;3:CD002047.:@0.547222:0.888703:0.615280:0.888703:0.615280:0.877873:0.547222:0.877873:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.002182:0.005665:0.005665:0.004364:0.004364:0.004364:0.004364:0.004364:0.004364:0.002182
2. Smolen JS, Landewé R, Bijlsma J, :@0.058296:0.896476:0.189138:0.896476:0.189138:0.885647:0.058296:0.885647:0.004364:0.002182:0.002182:0.005234:0.006536:0.004364:0.001742:0.004364:0.004364:0.002182:0.003923:0.005234:0.002182:0.002182:0.004364:0.004364:0.004364:0.004364:0.004364:0.005665:0.004364:0.002182:0.005665:0.002182:0.002182:0.005234:0.001742:0.001742:0.001742:0.003923:0.006536:0.004364:0.002182:0.003923:0.002182:0.002182
et al:@0.189138:0.896476:0.203970:0.896476:0.203970:0.885943:0.189138:0.885943:0.004364:0.002182:0.002182:0.004364:0.001742
. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. :@0.203970:0.896476:0.737834:0.896476:0.737834:0.885647:0.203970:0.885647:0.002182:0.002182:0.005234:0.005665:0.004364:0.005234:0.005665:0.002182:0.002612:0.004364:0.003923:0.004364:0.006536:0.006536:0.004364:0.004364:0.004364:0.004364:0.002182:0.001742:0.004364:0.004364:0.003923:0.002182:0.002182:0.004364:0.002612:0.002182:0.002182:0.004364:0.004364:0.002182:0.006536:0.004364:0.004364:0.004364:0.004364:0.004364:0.006536:0.004364:0.004364:0.002182:0.002182:0.004364:0.002182:0.002182:0.002612:0.004364:0.004364:0.004364:0.006536:0.004364:0.002182:0.004364:0.001742:0.004364:0.002182:0.004364:0.002612:0.002182:0.004364:0.002612:0.001742:0.002182:0.001742:0.003923:0.002182:0.005665:0.001742:0.002182:0.004364:0.002182:0.003923:0.003923:0.004364:0.002182:0.004364:0.004364:0.002182:0.001742:0.003923:0.002182:0.004364:0.004364:0.004364:0.002182:0.004364:0.001742:0.004364:0.001742:0.004364:0.004364:0.001742:0.003923:0.004364:0.001742:0.002182:0.004364:0.001742:0.003923:0.004364:0.004364:0.003923:0.004364:0.002612:0.006536:0.004364:0.004364:0.001742:0.002182:0.003923:0.001742:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.001742:0.002612:0.004364:0.004364:0.004364:0.006536:0.004364:0.002182:0.001742:0.003923:0.002182:0.004364:0.002612:0.004364:0.004364:0.003923:0.002182:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.002182:0.002182
Ann Rheum Dis:@0.737834:0.896476:0.792781:0.896476:0.792781:0.885943:0.737834:0.885943:0.005234:0.004364:0.004364:0.002182:0.005665:0.004364:0.004364:0.004364:0.006536:0.002182:0.005665:0.001742:0.003923
 2017;76:960-977.:@0.792781:0.896476:0.856484:0.896476:0.856484:0.885647:0.792781:0.885647:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.004364:0.004364:0.004364:0.002612:0.004364:0.004364:0.004364:0.002182
3. Maddison P, Kiely P, Kirkham B, :@0.058296:0.904250:0.180152:0.904250:0.180152:0.893421:0.058296:0.893421:0.004364:0.002182:0.002182:0.006536:0.004364:0.004364:0.004364:0.001742:0.003923:0.004364:0.004364:0.002182:0.004230:0.002182:0.002182:0.005234:0.001742:0.004364:0.001742:0.003923:0.002182:0.004230:0.002182:0.002182:0.005234:0.001742:0.002612:0.003923:0.004364:0.004364:0.006536:0.002182:0.005234:0.002182:0.002182
et al:@0.180152:0.904250:0.194985:0.904250:0.194985:0.893717:0.180152:0.893717:0.004364:0.002182:0.002182:0.004364:0.001742
. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus. :@0.194985:0.904250:0.504227:0.904250:0.504227:0.893421:0.194985:0.893421:0.002182:0.002182:0.004364:0.004364:0.001962:0.001962:0.004364:0.004364:0.004364:0.006536:0.001742:0.004364:0.004364:0.002182:0.001742:0.004364:0.002182:0.002612:0.004364:0.004364:0.004364:0.006536:0.004364:0.002182:0.004364:0.001742:0.004364:0.002182:0.004364:0.002612:0.002182:0.004364:0.002612:0.001742:0.002182:0.001742:0.003923:0.002182:0.002182:0.002612:0.004364:0.003923:0.004364:0.006536:0.006536:0.004364:0.004364:0.004364:0.004364:0.002182:0.001742:0.004364:0.004364:0.003923:0.002182:0.002182:0.004364:0.002612:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.002182:0.004364:0.002612:0.004364:0.003923:0.004364:0.003923:0.003923:0.002182:0.004364:0.002182:0.002182:0.003923:0.004364:0.004364:0.003923:0.004364:0.004364:0.003923:0.004364:0.003923:0.002182:0.002182
Rheumatology:@0.504227:0.904250:0.554820:0.904250:0.554820:0.893717:0.504227:0.893717:0.005665:0.004364:0.004364:0.004364:0.006536:0.004364:0.002182:0.004364:0.001742:0.004364:0.004364:0.003923
 2005;44:280-286.:@0.554820:0.904250:0.618524:0.904250:0.618524:0.893421:0.554820:0.893421:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.004364:0.004364:0.004364:0.002612:0.004364:0.004364:0.004364:0.002182
4. Alfaro-Lara R, Espinosa-Ortega HF, Arce-Salinas CA. On behalf of the PRECIS study group. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.:@0.058296:0.912024:0.858236:0.912024:0.858236:0.901195:0.058296:0.901195:0.004364:0.002182:0.001751:0.005234:0.001742:0.002182:0.004364:0.002612:0.004364:0.002612:0.004364:0.004364:0.002612:0.004364:0.002182:0.005665:0.002182:0.002182:0.005234:0.003923:0.004364:0.001742:0.004364:0.004364:0.003923:0.004364:0.002612:0.006105:0.002612:0.002182:0.004364:0.004364:0.004364:0.002182:0.005665:0.003923:0.002182:0.001751:0.005234:0.002612:0.003923:0.004364:0.002612:0.005234:0.004364:0.001742:0.001742:0.004364:0.004364:0.003923:0.002182:0.005665:0.005234:0.002182:0.002182:0.006105:0.004364:0.002182:0.004364:0.004364:0.004364:0.004364:0.001742:0.002182:0.002182:0.004364:0.002182:0.002182:0.002182:0.004364:0.004364:0.002182:0.005234:0.005665:0.005234:0.005665:0.002182:0.005234:0.002182:0.003923:0.002182:0.004364:0.004364:0.003923:0.002182:0.004364:0.002612:0.004364:0.004364:0.004364:0.002182:0.002182:0.005234:0.003923:0.003923:0.002182:0.004364:0.006536:0.004364:0.002182:0.001742:0.003923:0.002182:0.002612:0.004364:0.003923:0.001742:0.004364:0.005665:0.002182:0.004364:0.004364:0.004364:0.002182:0.006536:0.004364:0.002182:0.004364:0.002612:0.004364:0.004364:0.004364:0.001742:0.003923:0.003923:0.001742:0.003923:0.002182:0.004364:0.002182:0.002182:0.002182:0.004364:0.004364:0.002182:0.004364:0.002182:0.001962:0.001962:0.003923:0.004364:0.003923:0.003923:0.002182:0.004364:0.004364:0.004364:0.002182:0.003923:0.004364:0.002182:0.004364:0.002182:0.003923:0.002182:0.004364:0.002182:0.002182:0.001742:0.004364:0.001962:0.001962:0.004364:0.004364:0.004364:0.006536:0.001742:0.004364:0.004364:0.002182:0.004364:0.004364:0.004364:0.002182:0.006536:0.004364:0.002182:0.004364:0.004364:0.002182:0.002612:0.004364:0.003923:0.004364:0.002182:0.004364:0.002182:0.001742:0.004364:0.002182:0.002182:0.004364:0.004364:0.002182:0.002182:0.002612:0.004364:0.004364:0.002182:0.006536:0.004364:0.004364:0.002182:0.002182:0.004364:0.002182:0.002182:0.002612:0.004364:0.004364:0.004364:0.006536:0.004364:0.002182:0.004364:0.001742:0.004364:0.002182:0.004364:0.002612:0.002182:0.004364:0.002612:0.001742:0.002182:0.001742:0.003923:0.002182
 :@0.858331:0.912024:0.860513:0.912024:0.860513:0.901195:0.858331:0.901195:0.002182
 :@0.058296:0.919798:0.060478:0.919798:0.060478:0.908969:0.058296:0.908969:0.002182
Reumatol Clin:@0.066784:0.919798:0.116057:0.919798:0.116057:0.909265:0.066784:0.909265:0.005665:0.004364:0.004364:0.006536:0.004364:0.002182:0.004364:0.001742:0.002182:0.005665:0.001742:0.001742:0.004364
 2017. http://dx.doi.org/10.1016/j.reuma.2017.07.020:@0.116057:0.919798:0.298860:0.919798:0.298860:0.908969:0.116057:0.908969:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.002182:0.004364:0.002182:0.002182:0.004364:0.002182:0.002182:0.002182:0.004364:0.003923:0.002182:0.004364:0.004364:0.001742:0.002182:0.004364:0.002612:0.004364:0.002182:0.004364:0.004364:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.001742:0.002182:0.002612:0.004364:0.004364:0.006536:0.004364:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.004364:0.004364:0.004364
5. Rheumalef Tablets approved package insert. 2015.:@0.058296:0.927572:0.243989:0.927572:0.243989:0.916743:0.058296:0.916743:0.004364:0.002182:0.002182:0.005665:0.004364:0.004364:0.004364:0.006536:0.004364:0.001742:0.004364:0.002182:0.002048:0.003923:0.004364:0.004364:0.001742:0.004364:0.002182:0.003923:0.002182:0.004364:0.004364:0.004364:0.002612:0.004364:0.003923:0.004364:0.004364:0.002182:0.004364:0.004364:0.003923:0.003923:0.004364:0.004364:0.004364:0.002182:0.001742:0.004364:0.003923:0.004364:0.002612:0.002182:0.002182:0.002182:0.004364:0.004364:0.004364:0.004364:0.002182
6. Reference on request.:@0.058296:0.935346:0.144669:0.935346:0.144669:0.924517:0.058296:0.924517:0.004364:0.002182:0.002182:0.005665:0.004364:0.002182:0.004364:0.002612:0.004364:0.004364:0.003923:0.004364:0.002182:0.004364:0.004364:0.002182:0.002612:0.004364:0.004364:0.004364:0.004364:0.003923:0.002182:0.002182
RA – rheumatoid arthritis, MTX – methotrexate, DMARD – disease-modifying antirheumatic drug:@0.058296:0.868926:0.392362:0.868926:0.392362:0.858097:0.058296:0.858097:0.005665:0.004804:0.002182:0.004364:0.002182:0.002612:0.004364:0.004364:0.004364:0.006536:0.004364:0.002182:0.004364:0.001742:0.004364:0.002182:0.004364:0.002612:0.002182:0.004364:0.002612:0.001742:0.002182:0.001742:0.003923:0.002182:0.002182:0.006536:0.004794:0.005234:0.002182:0.004364:0.002182:0.006536:0.004364:0.002182:0.004364:0.004364:0.002182:0.002612:0.004364:0.003923:0.004364:0.002182:0.004364:0.002182:0.002182:0.005665:0.006536:0.005234:0.005665:0.005665:0.002182:0.004364:0.002182:0.004364:0.001742:0.003923:0.004364:0.004364:0.003923:0.004364:0.002612:0.006536:0.004364:0.004364:0.001742:0.002182:0.003923:0.001742:0.004364:0.004364:0.002182:0.004364:0.004364:0.002182:0.001742:0.002612:0.004364:0.004364:0.004364:0.006536:0.004364:0.002182:0.001742:0.003923:0.002182:0.004364:0.002612:0.004364:0.004364
IMPROVE:@0.528666:0.105648:0.708215:0.105648:0.708215:0.072583:0.528666:0.072583:0.011512:0.035395:0.025444:0.027707:0.029463:0.024741:0.025287
CLINICAL:@0.526753:0.139322:0.708215:0.139322:0.708215:0.106257:0.526753:0.106257:0.028722:0.022751:0.011512:0.028917:0.011473:0.028058:0.026888:0.023141
OUTCOMES,:@0.470247:0.172996:0.708215:0.172996:0.708215:0.139931:0.470247:0.139931:0.030127:0.028722:0.023141:0.028682:0.030243:0.035395:0.025248:0.025561:0.010849
DELAY DISEASE:@0.399809:0.206670:0.708215:0.206670:0.708215:0.173606:0.399809:0.173606:0.028761:0.025405:0.024234:0.023766:0.026029:0.010693:0.028839:0.011668:0.025561:0.026029:0.026575:0.025561:0.025287
PROGRESSION:@0.408706:0.240344:0.696976:0.240344:0.696976:0.207280:0.408706:0.207280:0.025444:0.027707:0.030204:0.029697:0.028058:0.025248:0.025756:0.025522:0.011473:0.030243:0.028917
1:@0.695548:0.225427:0.708197:0.225427:0.708197:0.206150:0.695548:0.206150:0.012650
RHEUMALEF:@0.093756:0.724206:0.383832:0.724206:0.383832:0.637025:0.093756:0.637025:0.033603:0.031839:0.027302:0.032763:0.047800:0.036879:0.026294:0.027302:0.026294
Leflunomide:@0.193317:0.751350:0.384009:0.751350:0.384009:0.697588:0.193317:0.697588:0.016785:0.019012:0.011423:0.011423:0.018960:0.018960:0.018753:0.028803:0.009118:0.018960:0.018494
 • Part of the guideline-recommended first treatment  :@0.399582:0.479403:0.914308:0.479403:0.914308:0.460025:0.399582:0.460025:0.005943:0.010689:0.008615:0.013853:0.011480:0.007119:0.006734:0.005943:0.012271:0.006328:0.005943:0.006734:0.011886:0.011480:0.005943:0.012271:0.011886:0.004746:0.012677:0.011480:0.004746:0.004746:0.011886:0.011480:0.008316:0.006734:0.011480:0.011480:0.012271:0.018236:0.018236:0.011480:0.011886:0.012677:0.011480:0.012677:0.005943:0.005537:0.005537:0.007119:0.010689:0.006734:0.005943:0.006734:0.006734:0.011480:0.011480:0.006734:0.018236:0.011480:0.011886:0.006734:0.005943:0.005943
  strategy for active RA  :@0.399582:0.498993:0.643553:0.498993:0.643553:0.479615:0.399582:0.479615:0.005943:0.019305:0.010689:0.006734:0.007119:0.011480:0.006734:0.011480:0.012271:0.010689:0.005943:0.006328:0.012271:0.007119:0.005943:0.011480:0.011480:0.006734:0.004746:0.010689:0.011480:0.005943:0.014644:0.013853:0.006928:0.005943
2:@0.630680:0.492100:0.637610:0.492100:0.637610:0.480802:0.630680:0.480802:0.006930
•  As effective as MTX and equally well-tolerated:@0.399584:0.538174:0.865482:0.538174:0.865482:0.518795:0.399584:0.518795:0.010689:0.005943:0.008615:0.013853:0.010689:0.005943:0.011480:0.005943:0.006328:0.011480:0.011480:0.006734:0.004746:0.010689:0.011480:0.005943:0.011480:0.010689:0.005943:0.018620:0.012271:0.013062:0.005943:0.011480:0.011886:0.012677:0.005943:0.011480:0.012677:0.011886:0.011480:0.004746:0.004746:0.010689:0.005943:0.016205:0.011480:0.004746:0.004746:0.008316:0.006734:0.012271:0.004746:0.011480:0.007119:0.011480:0.006734:0.011480:0.012677
3,4 :@0.865473:0.531280:0.886263:0.531280:0.886263:0.519983:0.865473:0.519983:0.006930:0.003465:0.006930:0.003465
•  Effective alone and in combination with other DMARDs:@0.399582:0.577354:0.948000:0.577354:0.948000:0.557976:0.399582:0.557976:0.010689:0.005943:0.008615:0.013062:0.005943:0.006328:0.011480:0.011480:0.006734:0.004746:0.010689:0.011480:0.005900:0.011480:0.004746:0.012271:0.011886:0.011480:0.005900:0.011480:0.011886:0.012677:0.005900:0.004746:0.011886:0.005900:0.011480:0.012271:0.018236:0.012677:0.004746:0.011886:0.011480:0.006734:0.004746:0.012271:0.011886:0.005900:0.016205:0.004746:0.006734:0.011886:0.005900:0.012271:0.006734:0.011886:0.011480:0.007119:0.005900:0.015050:0.018620:0.013853:0.014644:0.015050:0.010689
2 :@0.948034:0.570461:0.958429:0.570461:0.958429:0.559163:0.948034:0.559163:0.006930:0.003465
•  Convenient once-daily dosing:@0.399582:0.616535:0.709525:0.616535:0.709525:0.597157:0.399582:0.597157:0.010689:0.005943:0.008615:0.015435:0.012271:0.011886:0.010689:0.011480:0.011886:0.004746:0.011480:0.011886:0.006734:0.005943:0.012271:0.011886:0.011480:0.011480:0.008316:0.012677:0.011480:0.004746:0.004746:0.010689:0.005943:0.012677:0.012271:0.010689:0.004746:0.011886:0.012271
5 :@0.709522:0.609642:0.719917:0.609642:0.719917:0.598344:0.709522:0.598344:0.006930:0.003465
First branded :@0.833728:0.047493:0.957773:0.138969:0.977868:0.123078:0.853822:0.031603:0.010738:0.005202:0.007487:0.009772:0.006837:0.005536:0.011072:0.007487:0.010422:0.011072:0.011072:0.010738:0.011072:0.196113
generic to :@0.827861:0.074291:0.922907:0.144382:0.943002:0.128491:0.847956:0.058401:0.010738:0.010738:0.011072:0.010738:0.007487:0.005202:0.010422:0.005536:0.006837:0.010738:0.223890
market:@0.813083:0.094518:0.875264:0.140372:0.895359:0.124482:0.833178:0.078627:0.016275:0.010422:0.007487:0.010422:0.010738:0.278085
5,6:@0.882572:0.134594:0.898720:0.146502:0.910436:0.137238:0.894288:0.125330:0.006455:0.003238:0.237542
6811 Rheumalef MIMS Advert.indd   1:@0.027168:1.030146:0.199741:1.030146:0.199741:1.021538:0.027168:1.021538:0.005660:0.005660:0.005660:0.005660:0.002830:0.007350:0.005660:0.005660:0.005660:0.008480:0.005660:0.002260:0.005660:0.002830:0.002830:0.008480:0.002830:0.008480:0.006790:0.002830:0.006790:0.005660:0.005090:0.005660:0.003390:0.002830:0.002830:0.002260:0.005660:0.005660:0.005660:0.002830:0.002830:0.002830:0.005660
2019/05/21   11:54:@0.928579:1.030146:1.013481:1.030146:1.013481:1.021538:0.928579:1.021538:0.005660:0.005660:0.005660:0.005660:0.002830:0.005660:0.005660:0.002830:0.005660:0.005660:0.002830:0.002830:0.002830:0.005660:0.005660:0.002830:0.005660:0.005660